Researchers from the Indian Institute of Technology (IIT) Bombay and Monash University have announced a simpler and more efficient method for lab-grown T-cell recovery. This breakthrough directly impacts T-cell-based cancer therapies, like the critical CAR T-cell treatment. The technique specifically addresses the challenge of retrieving large numbers of viable cells from three-dimensional culture scaffolds.
The Challenge of T-Cell Expansion and Retrieval
Immunotherapy leverages the body’s immune system to identify and destroy malignant cells. A core example is CAR T-cell therapy, where doctors genetically modify a patient’s T-cells in the laboratory. They grow these modified cells in massive quantities before infusing them back into the patient’s bloodstream to combat cancer. A constant requirement for T-cell-based immunotherapy remains an ample supply of healthy, functional T-cells.
Therefore, growing these cells outside the body and collecting them gently for re-infusion is crucial. IIT Bombay’s team, led by Prof. Prakriti Tayalia, developed electrospun scaffolds to mimic the body’s natural tissue environment. Earlier studies confirmed that T-cells grown on these scaffolds become more active and multiply rapidly. However, a problem arises because T-cells move deep within the fibers, becoming tightly lodged and difficult to remove. This inefficiency in cell collection significantly hinders the overall therapeutic process.
Enhancing T-cell Recovery with Milder Enzymes
Prof. Tayalia noted that cell recovery turns out to be one of the biggest challenges in practice. Without enough healthy cells, proper testing for the therapy is not possible. The team tested Jurkat T-cells, a human cell line used to study T-cell biology, inside polycaprolactone electrospun scaffolds. The researchers observed that the cells actively moved and lodged tightly between the fibers. Standard manual flushing with growth medium failed to detach all the cells, particularly those stuck at fiber junctions.
Consequently, the team tested three detachment methods: manual flushing, TrypLE (a version of trypsin), and Accutase (a milder enzyme). They found that Accutase successfully recovered cells with greater survival rates. Moreover, the recovered cells behaved more like healthy, active T-cells; they formed clusters, which is an essential precursor to cell division and continued growth. Trypsin and other harsh treatments can damage key surface proteins required for immune signaling, reducing the therapeutic usefulness of the cells. In contrast, Accutase appears mild enough to avoid this critical problem, preserving cell viability and function.
This finding is a major step forward, suggesting laboratories can now use such scaffolds effectively for preparing cells for treatments such as CAR T-cell therapy. Prof. Tayalia emphasized that every step matters when making advanced therapies accessible to patients. Researchers plan to test these findings in animal models and explore placing T-cell-loaded scaffolds directly inside the body in the future. Building on this successful work, the team also confirmed that T-cells grown on their scaffolds kill cancer cells more effectively. Professionals looking to advance their knowledge in this rapidly evolving field should consider further training in Clinical Oncology.
Frequently Asked Questions
Q1: What is the primary challenge addressed by the new IIT Bombay method?
The main challenge is the efficient and gentle retrieval of a sufficient number of live, functional T-cells that have been grown and expanded within fibrous, three-dimensional electrospun scaffolds.
Q2: Why is Accutase superior to TrypLE or manual flushing for T-cell recovery?
Accutase is a milder enzyme that preserves the vital surface proteins needed for T-cell immune signaling and activation. Cells recovered with Accutase show higher survival rates and better post-recovery clustering compared to those treated with harsher enzymes like TrypLE or trypsin.
References
- IIT Bombay develops simpler method to recover lab-grown immune cells fortreating cancer – ETHealthworld
- Accutase Cell Detachment Solution: Gentle on Cells, Powerful in Performance – Procell
- IIT Bombay’s New Method Improves T-Cell Cancer Therapy – New Kerala
- IIT Bombay Develops Gentler Method to Recover T Cells for Cancer Therapies – India New England
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.